Healthcare Industry News: Ampion
News Release - January 16, 2019
Lisa Genova, Ph.D joins CereVasc Board of DirectorsBOSTON, Jan. 16, 2019 -- (Healthcare Sales & Marketing Network) -- CereVasc, LLC, a company focused on improving the care of patients with communicating hydrocephalus announced today the addition of acclaimed neuroscientist and author Lisa Genova, Ph.D., to the Board of Directors.
Dr. Genova is the New York Times bestselling author of several novels inspired by neuroscience and the human spirit. Her works include Still Alice, which was adapted into an Oscar winning film by the same name, Left Neglected, Love Anthony, Inside the O'Briens, and Every Note Played.
"We are delighted to have Lisa join our team. Lisa's graduate training in neuroscience combined with her expertise and knowledge of neurodegenerative disease will be very valuable to CereVasc as we continue to pursue evidence to support use of our technology in treating dementia associated with normal pressure hydrocephalus, future application of our technology in delivery of therapeutic agents directly to the central nervous system, and further evaluate the use of our approach in treating other neurodegenerative diseases," said Dan Levangie, Chairman & CEO of CereVasc, LLC.
"CereVasc's vision for cerebrospinal fluid management is unique, innovative, and important for patients," said Dr. Genova. "I look forward to working with CereVasc in advancing their technology as we strive to treat a variety of brain disorders."
Dr. Genova graduated valedictorian from Bates College with a degree in biopsychology and holds a Ph.D. in neuroscience from Harvard University. She travels worldwide speaking about the neurological diseases she writes about and has appeared on The Dr. Oz Show, Today, PBS NewsHour, CNN, and NPR. Her TED talk, What You Can Do To Prevent Alzheimer's, has been viewed more than 3.5 million times.
Lisa was named one of the U.S. Top 50 Influencers in Aging by Next Avenue. She received The Pell Center Prize for Story in the Public Square, for "distinguished storytelling that has enriched the public dialogue," The Sargent and Eunice Shriver Profiles in Dignity Award, the National Alzheimer's Association's Rita Hayworth Award, The Global Genes RARE ChAmpions of Hope Award, and The American College of Neuropsychopharmacology Media Award for "informing the public about Treatment and ongoing research in medical illness."
About CereVasc, LLC
CereVasc, LLC is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. The Company's first product, the eShunt™ System, is an endovascularly deliverable cerebrospinal fluid shunt and associated delivery componentry designed to avoid the need for invasive surgery, general anesthesia and hospitalization associated with the current surgical treatment of communicating hydrocephalus using ventriculo-peritoneal shunts.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.